Osteoporosis in men

Saudi Medical Journal

Volumn 26, Issue 4, 2005, Pages 519-523

  Faraawi, Rafat ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALENDRONIC ACID; ALFACALCIDOL; ANDROGEN; BISPHOSPHONIC ACID DERIVATIVE; CALCITRIOL; CALCIUM; CORTICOSTEROID; PARATHYROID HORMONE[1-34]; PLACEBO; RISEDRONIC ACID; TESTOSTERONE; VITAMIN D;

ADULTHOOD; ALCOHOL CONSUMPTION; BONE DENSITY; CHILDHOOD; CIGARETTE SMOKING; CLINICAL TRIAL; CORTICOSTEROID INDUCED OSTEOPOROSIS; DATA ANALYSIS; DISEASE ASSOCIATION; DRUG EFFICACY; DUAL ENERGY X RAY ABSORPTIOMETRY; EXERCISE; FRAGILITY FRACTURE; HUMAN; MALE; MEDICAL DECISION MAKING; MORTALITY; OSTEOPOROSIS; PHYSICAL ACTIVITY; PREVALENCE; PROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; SCORING SYSTEM; TREATMENT PLANNING; VERTEBRA FRACTURE;

EID: 19044375494     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Tenenhouse A, Joseph L, Kreiger N. Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int 2000; 11: 897-904.
2. Lunt M, Felsenberg D, Reeve J. Bone density variation and its effects on risk of vertebral deformity in men and women studied in thirteen European centers: the EVOS Study. J Bone Miner Res 1997; 12: 1883-1894.
3. Davies KM, Stegman MR, Heaney RP, Recker RR. Prevalence and severity of vertebral fracture: the Saunders County Bone Quality Study. Osteoporos Int 1996; 6: 160-165.
4. Looker AC, Orwoll ES, Johnston CC. Prevalence of low femoral bone density in older U.S. adults from NHANES III. J Bone Miner Res 1997; 12: 1761-1768.
5. Kanis JL, Melton LJ, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res 1994; 9: 1137-1141.
6. Orwoll ES, Klein RF. Osteoporosis in men. Endocr Rev 1995; 16: 87-116.
7. Seeman E. During aging, men lose less bone than women because they gain more periosteal bone, not because they resorb less endosteal bone. Calcif Tissue Int 2001; 69: 205-208.
8. Kanis JA, Johnell O, Oden A. Long-term risk of osteoporotic fracture in Malmo. Osteoporosis Int 2000; 11: 669-674.
9. Jones G, Nguyen T, Sambrook PN. Symptomatic fracture incidence in elderly men and women: the Dubbo Osteoporosis Epidemiology Study (DOES). Osteoporos Int 1994; 4: 277-282.
10. Mussolino ME, Looker AC, Madans JH. Risk factors for hip fracture in white men: the NHANES I Epidemiologic Follow-up Study. J Bone Miner Res 1998; 13: 918-924.
11. Center JR, Nguyen TV, Schneider D. Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet 1999; 353: 878-882.
12. Cheng S, Suominen H, Sakari-Rantala R. Calcaneal bone mineral density predicts fracture occurrence: a five-year follow-up study in elderly people. J Bone Miner Res 1997; 12: 1075-1082.
13. De Laet CE, Van Hout BA, Burger H. Hip fracture prediction in elderly men and women: validation in the Rotterdam study. J Bone Miner Res 1998; 13: 1587-1593.
14. Cuddihy MT, Gabriel SE, Crowson CS, O'Fallon WM, Melton III LJ. Forearm fractures as predictors of subsequent osteoporotic fractures. Osteoporosis Int 1999; 9: 496-475.
15. Melton LJ, Atkinson EJ, Cooper C, O'Fallon WM, Riggs BL. Vertebral fractures predict subsequent fractures. Osteoporosis Int 1999; 10: 214-221.
16. Mallmin H, Ljunghall S, Persson I, Naessen T, Krusemo UB, Bergstrom R, et al. Fracture of the distal forearm as a forecaster of subsequent hip fracture. A population-based cohort study with 24-year follow-up. Calcif Tissue Int 1993; 52: 269-272.
17. Ismail AA, O'Neill TW, Cooper C, Silman AJ. Risk factors for vertebral deformities in men: relationship to number of vertebral deformities. European Vertebral Osteoporosis Study Group. J Bone Miner Res 2000; 15: 278-283.
18. Johnell O, Oden A, Caulin F, Kanis JA. Acute and long-term increase in fracture risk after hospitalization for vertebral fracture. Osteoporos Int 2001; 12: 207-214.
19. Jones G, Nguyen T, Sambrook P. Progressive loss of bone in the femoral neck in elderly people: longitudinal findings from the Dubbo osteoporosis epidemiology study. BMJ 1994; 309: 691-695.
20. Tanaka, T, Latorre MR, Jaime PC, Florindo AA, Pippa MG, Zerbini CA. Risk factors for proximal femur osteoporosis in men aged 50 years or older. Osteoporos Int 2001; 12: 942-949.
21. Eastell R, Boyle IT, Compston J. Management of male osteoporosis: report of the UK Consensus Group. QJM 1998; 91: 71-92.
22. Stanley HL, Schmitt BP, Poses RM, Deiss WP. Does hypogonadism contribute to the occurrence of a minimal trauma hip fracture in elderly men? J Am Geriatr Soc 1991; 39: 766-771.
23. Felson DT, Kiel DP, Anderson JJ, Kannel WB. Alcohol consumption and hip fractures: the Framingham Study. Am J Epidem 1988; 128: 1102-1110.
24. Grisso JA, Chiu GY, Maislin G, Steinmann WC, Portale J. Risk factors for hip fractures in men: a preliminary study. J Bone Miner Res 1991; 6: 865-868.
25. Israel Y, Orrego H, Holt S, Macdonald DW, Meema HE. Identification of alcohol abuse: thoracic fractures on routine chest x-rays as indicators of alcoholism. Alcohol Clin Exp Res 1980; 4: 420-422.
26. Ortego-Centeno N, Munoz-Torres M, Jodar E, Hernandez-Quero J, Duce A, Torres-Puchol JDLH. Effect of tobacco consumption on bone mineral density in healthy young males. Calcif Tissue Int 1997; 60: 496-500.
27. Bendavid EJ, Shan J, Barrett-Connor EL. Factors associated with bone mineral density in middle-aged men. J Bone Miner Res 1996; 11: 1185-1190.
28. Scane AC, Francis RM, Sutcliffe AM, Francis MJ, Rawlings DJ, Chapple CL. Case-control study of the pathogenesis and sequelae of symptomatic vertebral fractures in men. Osteoporos Int 1999; 9: 91-97.
29. Nguyen TV, Center JR, Eisman JA. Osteoporosis in elderly men and women: effects of dietary calcium, physical activity, and body mass index. J Bone Miner Res 2000; 15: 322-331.
30. Bendavid EJ, Shan J, Barrett-Connor EL. Factors associated with bone mineral density in middle-aged men. J Bone Miner Res 1996; 11: 1185-1190.
31. McKay HA, Petit MA, Schutz RW. Augmented trochanteric bone mineral density after modified physical education classes: a randomized school-based exercise intervention study in prepubescent and early pubescent children. J Pediatr 2000; 136: 156-162.
32. Kujala UM, Kaprio J, Kannus P. Physical activity and osteoporotic hip fracture risk in men. Arch Intern Med 2000; 160: 705-708.
33. Paganini-Hill A, Chao A, Ross RK, Henderson BE. Exercise and other factors in the prevention of hip fracture: the Leisure World study. Epidemiology 1991; 2: 16-25.
34. Silman AJ, O'Neill TW, Cooper C. Influence of physical activity on vertebral deformity in men and women: results from the European Vertebral Osteoporosis Study. J Bone Miner Res 1997; 12: 813-819.
35. Nelson ME, Fiatarone MA, Morganti CM. Effects of high-intensity strength training on multiple risk factors for osteoporotic fractures. A randomized controlled trial. JAMA 1994; 272: 1909-1914.
36. Hoidrup S, Gronbaek M, Gottschau A. Alcohol intake, beverage preference, and risk of hip fracture in men and women. Copenhagen Centre for Prospective Population Studies. Am J Epidemiol 1999; 149: 993-1001.
37. Orwoll E, Ettinger M, Weiss S. Alendronate for the treatment of osteoporosis in men. N Engl J Med 2000; 343: 604-610.
38. Ringe JD, Faber H, Dorst A. Alendronate treatment of established primary osteoporosis in men: results of a 2-year prospective study. J Clin Endocrinol Metab 2001; 86: 5252-5255.
39. Adachi JD, Bensen WG, Brown J. Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. N Engl J Med 1997; 337: 382-387.
40. Saag KG, Emkey R, Schnitzer TJ. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group. N Engl J Med 1998; 339: 292-299.
41. Reid DM, Hughes RA, Laan RF. Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial. European Corticosteroid-Induced Osteoporosis Treatment Study. J Bone Miner Res 2000; 15: 1006-1013.
42. Wallach S, Cohen S, Reid DM. Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy. Calcif Tissue Int 2000; 67: 277-285.
43. Adachi JD, Saag KG, Delmas PD. Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial. Arthritis Rheum 2001; 44: 202-211.
44. Reid DM, Adami S, Devogelaer JP, Chines AA. Risedronate increases bone density and reduces vertebral fracture risk within one year in men on corticosteroid therapy. Calcif Tissue Int 2001; 69: 242-247.
45. Snyder PJ, Peachey H, Berlin JA. Effects of testosterone replacement in hypogonadal men. J Clin Endocrinol Metab 2000; 85: 2670-2677.
46. Behre HM, Kliesch S, Leifke E. Long-term effect of testosterone therapy on bone mineral density in hypogonadal men. J Clin Endocrinol Metab 1997; 82: 2386-2390.
47. Finkelstein JS, Klibanski A, Neer RM. Increases in bone density during treatment of men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 1989; 69: 776-783.
48. Snyder PJ, Peachey H, Hannoush P. Effect of testosterone treatment on bone mineral density in men over 65 years of age. J Clin Endocrinol Metab 1999; 84: 1966-1972.
49. Anderson FH, Francis RM, Peaston RT, Wastell HJ. Androgen supplementation in eugonadal men with osteoporosis: effects of six months treatment on markers of bone formation and resorption. J Bone Miner Res 1997; 12: 472-478.
50. Slovik DM, Rosenthal DI, Doppelt SH. Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1-34) and 1,25-dihydroxyvitamin D. J Bone Miner Res 1986; 1: 377-381.
51. Kurland ES, Cosman F, McMahon DJ. Parathyroid hormone as a therapy for idiopathic osteoporosis in men: effects on bone mineral density and bone markers. J Clin Endocrinol Metab 2000; 85: 3069-3076.
52. Neer RM, Arnaud CD, Zanchetta JR. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001; 344: 1434-1441.